期刊
JOURNAL OF CHILD NEUROLOGY
卷 31, 期 6, 页码 743-749出版社
SAGE PUBLICATIONS INC
DOI: 10.1177/0883073815620676
关键词
claims database; epilepsy; incidence; prevalence; US pediatric population
资金
- UCB Pharma
- Cyberonics, Inc.
- Centers for Disease Control and Prevention
- GlaxoSmithKline
- University of Alabama
This study aims to determine prevalence and incidence of epilepsy in the US pediatric population. We analyzed commercial claims and Medicaid insurance claims data between 2008 and 2012. Over 8 million continuously enrolled lives aged 0 to 19 years were included. Our definition of a prevalent case of epilepsy was based on International Classification of Diseases-coded diagnoses of epilepsy or seizures and evidence of prescribed antiepileptic drugs. Incident cases were identified in subjects continuously enrolled for 2 years of which the first 2 years had no indication of epilepsy or seizures. The overall prevalence estimate for 2012 was 6.8 per 1,000 children. The overall incidence estimate for 2012 was 104 per 100,000 pediatric population. This study provides estimates of the prevalence and incidence of epilepsy in the US pediatric population, using large claims datasets from multiple US population sectors. The findings appear reasonably representative of the US-insured pediatric population.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据